- Bioanalysis
- Bioelectronics
- Biosensors
- +۷ مورد دیگر
Prof. Frieder W. Scheller is affiliated with the Institute of Biochemistry and Biology at the University of Potsdam, Germany. His work centers on advanced biosensing technologies, particularly molecularly imprinted polymers (MIPs), bioelectronics, and biomimetic recognition systems. Research Interests: His primary fields include Bioanalysis, Bioelectronics, Biosensors, Molecularly Imprinted Polymers, Electrochemical Sensing, and Plastibodies. His research bridges chemistry, materials science, and biotechnology to develop synthetic alternatives to biological receptors for medical and environmental applications. The recent publications (2019–2024) highlight a strong trend in designing MIP-based nanofilms for protein and virus recognition, including applications in SARS-CoV-2 detection and enzyme monitoring. These studies focus on improving selectivity, stability, and reliability of electrochemical biosensors using innovative polymer architectures. Scientific Contributions: Developed Strep-tag imprinted polymer platforms for bio(electro)catalysis. Explored ACE2-mimicking MIPs for viral epitope recognition. Investigated challenges in MIP sensor reliability and non-specific binding. Advanced the concept of plastibodies for biomacromolecules, viruses, and cells. Collaborations and Advising: Prof. Scheller has collaborated with over 145 co-authors globally, indicating strong network engagement. While no formal students are listed in the provided text, his collaborative output suggests mentorship and team leadership roles in multidisciplinary research projects involving materials, electrochemistry, and biotechnology. Laboratories and Research Teams: His work is conducted within the Institute of Biochemistry and Biology at the University of Potsdam, likely involving a research group focused on bioanalytical chemistry and sensor development. The frequent co-authorship with researchers like Aysu Yarman and Xiaorong Zhang indicates an active, interdisciplinary team working on next-generation biosensing platforms.












